Neuroimaging biomarkers of small vessel disease in cerebral amyloid angiopathy‐related intracerebral hemorrhage

The significance of the correlation of computed tomography (CT)–based cerebral small vessel disease (SVD) markers with the clinical outcomes in patients with cerebral amyloid angiopathy (CAA)‐related intracerebral hemorrhage (ICH) remains uncertain. Thus, this study aimed to explore the relationship between SVD markers and short‐term outcomes of CAA‐ICH.

[1]  J. Mocco,et al.  2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. , 2022, Stroke.

[2]  J. Hendrikse,et al.  Cortical cerebral microinfarcts on 7T MRI: Risk factors, neuroimaging correlates and cognitive functioning – The Medea-7T study , 2021, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Klaus P. Ebmeier,et al.  Association of cerebral small vessel disease burden with brain structure and cognitive and vascular risk trajectories in mid-to-late life , 2021, medRxiv.

[4]  D. Werring,et al.  Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage , 2021, Neurology.

[5]  F. Shen,et al.  The Predictive Values of Different Small Vessel Disease Scores on Clinical Outcomes in Mild ICH Patients , 2021, Journal of atherosclerosis and thrombosis.

[6]  S. Greenberg,et al.  Association of Cerebral Small Vessel Disease and Cognitive Decline After Intracerebral Hemorrhage , 2020, Neurology.

[7]  J. Wardlaw,et al.  Association between Computed Tomographic Biomarkers of Cerebral Small Vessel Diseases and Long‐Term Outcome after Spontaneous Intracerebral Hemorrhage , 2020, Annals of neurology.

[8]  X. Ji,et al.  Treatment of intracerebral hemorrhage: Current approaches and future directions , 2020, Journal of the Neurological Sciences.

[9]  Zheng-yu Jin,et al.  Brain deep medullary veins on 3-T MRI in a population-based cohort , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  P. Huang,et al.  Venous disruption affects white matter integrity through increased interstitial fluid in cerebral small vessel disease , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  Yong-sook Park,et al.  MRI Assessment of Cerebral Small Vessel Disease in Patients with Spontaneous Intracerebral Hemorrhage , 2019, Yonsei medical journal.

[12]  Ming Liu,et al.  Total Burden of Cerebral Small Vessel Disease in Recurrent ICH versus First-ever ICH , 2019, Aging and disease.

[13]  Zhiyuan Yu,et al.  Prognostic significance of leukoaraiosis in intracerebral hemorrhage: A meta-analysis , 2019, Journal of the Neurological Sciences.

[14]  Sung-Chun Tang,et al.  Advances in cerebral amyloid angiopathy imaging , 2019, Therapeutic advances in neurological disorders.

[15]  J. Helenius,et al.  Cerebral small vessel disease burden and functional and radiographic outcomes in intracerebral hemorrhage , 2018, Journal of Neurology.

[16]  K. Arai,et al.  White-matter repair: Interaction between oligodendrocytes and the neurovascular unit , 2018, Brain circulation.

[17]  J. Lee,et al.  Impact of brain atrophy on 90-day functional outcome after moderate-volume basal ganglia hemorrhage , 2018, Scientific Reports.

[18]  J. Lee,et al.  Impact of brain atrophy on 90-day functional outcome after moderate-volume basal ganglia hemorrhage , 2018, Scientific Reports.

[19]  Eric E. Smith,et al.  Cerebral amyloid angiopathy as a cause of neurodegeneration , 2018, Journal of neurochemistry.

[20]  Eric E. Smith,et al.  Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds , 2017, Neurology.

[21]  C. Ayata,et al.  Emerging concepts in sporadic cerebral amyloid angiopathy. , 2017, Brain : a journal of neurology.

[22]  M. van Buchem,et al.  Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study , 2017, The Lancet Neurology.

[23]  Panagiotis Fotiadis,et al.  Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study , 2016, The Lancet Neurology.

[24]  Jiguang Wang,et al.  Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage , 2016, Stroke.

[25]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[26]  M. Bendszus,et al.  Cerebral Atrophy is an Independent Risk Factor for Unfavorable Outcome After Spontaneous Supratentorial Intracerebral Hemorrhage , 2013, Stroke.

[27]  S. Manjila,et al.  Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management. , 2012, Neurosurgical focus.

[28]  D. Werring,et al.  Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  S. Greenberg,et al.  Prevalence of Superficial Siderosis in Patients with Cerebral Amyloid Angiopathy , 2010, Neurology.

[30]  W. M. van der Flier,et al.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  L. Pantoni.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[32]  D. Gladstone,et al.  CT Angiography “Spot Sign” Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage , 2007, Stroke.